Roivant Sciences Business Segments — Gain (Loss) on Investments decreased by 83.2% to $21.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from -$21.31M to $21.59M. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive values indicate successful investment performance, while negative values indicate market volatility or poor asset selection.
This reflects the change in the market value of financial investments held by the segment, including realized and unreal...
Common for companies with significant cash reserves or strategic venture portfolios.
roiv_segment_reportable_segment_gain_loss_on_investments| Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$11.99M | -$11.99M | -$11.99M | -$11.99M | $15.23M | $48.38M | -$21.31M | $12.90M | $128.50M | $21.59M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +227.0% | +217.7% | -144.1% | +160.5% | +896.2% | -83.2% |
| YoY Change | — | — | — | — | +227.0% | +503.4% | -77.7% | +207.6% | +165.6% | +201.3% |